Technology | November 26, 2007

Medrad Displays "CT Contrast Injection of the Future," Highlights CT Enhancements

Medrad Inc. displayed at RSNA 2007 “CT Contrast Injection of the Future,” an exhibit about the leading role of contrast injection in CT imaging, as well as patient safety, patient-specific protocol optimization and workflow and data integration innovations that are in development by the company.

Medrad also highlighted advancements made to its Stellant CT Injection System, featuring the DualFlow simultaneous injection and scanner-injector interface technology, as well as two new additions: CardiacFlow powered by P3TTM and XDSTM Extravasation Detector.

CardiacFlow is the first application of Medrad’s P3T, Personalized Patient Protocol Technology, which uses patient-specific parameters to optimize injection timing and contrast volume, and is specifically designed for cardiac CT imaging procedures. It is U.S. FDA 510(k) pending and patent pending.

The Medrad XDS Extravasation Detector is a patented product designed to prevent moderate to severe contrast extravasations that may seriously injure patients. Because XDS technology directly senses fluid pooling under the skin to stop an injection during a CT procedure, it reportedly minimizes false positives to maintain efficient workflow. XDS is U.S. FDA 510(k) cleared as of March 2007.

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Feature | Computed Tomography (CT) | July 03, 2018 | By Jeff Zagoudis
Stroke is the fifth leading cause of death in the United States, responsible for more than 140,000 deaths in some of
Neusoft Medical Systems USA Introducing NeuViz 16 Essence CT at AHRA 2018
Technology | Computed Tomography (CT) | June 27, 2018
At the 2018 Association for Medical Imaging Management (AHRA) Annual Meeting, July 22-25 in Orlando, Fla., Neusoft...
Smoking and Diabetes Linked to Brain Calcifications
News | Neuro Imaging | June 26, 2018
People who smoke or have diabetes may be at increased risk of calcifications in a region of the brain crucial to memory...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Overlay Init